Impact of COVID-19 pandemic on SLE: beyond the risk of infection.

Horisberger, Alice; Moi, Laura; Ribi, Camillo; Comte, Denis

Horisberger, Alice; Moi, Laura; Ribi, Camillo; Comte, Denis.

Horisberger A; Service of Immunology and Allergy, Departement de medecine, Centre hospitalier universitaire vaudois, Lausanne, Switzerland.
Moi L; Service of Immunology and Allergy, Departement de medecine, Centre hospitalier universitaire vaudois, Lausanne, Switzerland.
Ribi C; Service of Immunology and Allergy, Departement de medecine, Centre hospitalier universitaire vaudois, Lausanne, Switzerland.
Comte D; Service of Immunology and Allergy, Departement de medecine, Centre hospitalier universitaire vaudois, Lausanne, Switzerland denis.comte@chuv.ch.

Lupus Sci Med ; 7(1)2020 05.

Article in English | MEDLINE | ID: covidwho-217001

Subject(s)

Coronavirus Infections/prevention & control; Lupus Erythematosus, Systemic/diagnosis; Lupus Erythematosus, Systemic/drug therapy; Pandemics/prevention & control; Pneumonia, Viral/prevention & control; Betacoronavirus/isolation & purification; COVID-19; Coronavirus Infections/epidemiology; Coronavirus Infections/virology; Humans; Pneumonia, Viral/epidemiology; Pneumonia, Viral/virology; SARS-CoV-2

Keywords

antirheumatic agents; interferon type I; lupus erythematosus, systemic

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics / Lupus Erythematosus, Systemic Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Humans Language: English Year: 2020 Document Type: Article Affiliation country: Lupus-2020-000408

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google